Avantor (NYSE:AVTR) is a global provider of products, services and solutions used in the life sciences and advanced technology industries. The company supplies materials and equipment that support research, drug discovery and development, biopharmaceutical manufacturing, clinical and diagnostic activities, and other laboratory applications.
Its offerings include laboratory chemicals and reagents, consumables, single-use manufacturing technologies, bioprocessing products, equipment, and related services. Avantor serves pharmaceutical and biotechnology companies, healthcare organizations, academic and research institutions, government agencies, and customers in the semiconductor and other advanced technology sectors.
The company operates internationally, serving customers across North America, Europe, Asia and other global markets. Avantor expanded significantly through its 2017 acquisition of VWR, a major laboratory products and distribution business, and subsequently has continued developing its portfolio of products and services for research, production and healthcare applications.
